Newly Designed Cysteine-Based Self-Assembling Prodrugs for Sepsis Treatment

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Nanomedicine

Background:

• Reactive oxygen species (ROS) are critical for cell signaling but their overproduction leads to redox imbalance and disease.
• Existing antioxidants often exhibit limited efficacy, necessitating the development of novel strategies.
• Cysteine (Cys), a natural amino acid, possesses antioxidant properties that can be harnessed for therapeutic applications.

Purpose of the Study:

• To design and synthesize novel polymer-based antioxidants utilizing cysteine.
• To characterize the self-assembly and stability of these cysteine-based nanoparticles.
• To evaluate the therapeutic potential of the developed nanoparticles in a sepsis model.

Main Methods:

• Synthesis of amphiphilic block copolymers comprising poly(ethylene glycol) (PEG) and poly(cysteine) (PCys) segments.
• Protection of cysteine's thiol groups using a thioester moiety within the PCys segment.
• Characterization of nanoparticle formation (Nano^Cys(Bu)) using dynamic light scattering (DLS) and assessment of their stability across a pH range.
• In vivo evaluation of Nano^Cys(Bu) efficacy in a lipopolysaccharide (LPS)-induced sepsis model in mice.

Main Results:

• Successfully synthesized amphiphilic block copolymers that self-assembled into nanoparticles (Nano^Cys(Bu)) with hydrodynamic diameters ranging from 40-160 nm.
• Nano^Cys(Bu) exhibited stability in aqueous conditions across a pH range of 2 to 8.
• In a mouse model of sepsis, Nano^Cys(Bu) administration significantly prolonged survival time compared to control groups.
• The developed nanoparticles demonstrated potential for enhancing antioxidative efficacy and mitigating adverse effects.

Conclusions:

• Novel polymer-based nanoparticles incorporating cysteine were successfully developed.
• These nanoparticles display favorable self-assembly characteristics and stability, making them suitable for biomedical applications.
• The study highlights the therapeutic promise of Nano^Cys(Bu) in managing sepsis by improving antioxidant capacity and extending survival.